Herpes simplex virus type 2 and cancer of the prostate.
A seroepidemiologic study was performed to determine if there was an association between antibodies to herpes simplex virus type 2 and cancer of the prostate, similar to that reported for herpes simplex virus type 2 and cervical carcinoma. No significant difference in herpes simplex virus type 2 antibodies was seen between patients with cancer of the prostate and those with benign prostatic hypertrophy. Further studies are needed to define the possible role of herpes simplex virus type 2 in the etiology of cancer of the prostate.
D000914:Antibodies, Viral / Q000032:analysis; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000276:immunology / Q000382:microbiology; D011471:Prostatic Neoplasms / Q000276:immunology / Q000382:microbiology*; D012703:Serotyping; D018139:Simplexvirus / Q000276:immunology / Q000472:pathogenicity*; D012959:Socioeconomic Factors
D000914:Antibodies, Viral